Thus, we here propose the existence of other mechanisms regulating neuroblastoma trafficking to the BM and/or increasing responsiveness of neuroblastoma to SDF-1 by sensitization or overexpression of the CXCR4. The gene discussed is CXCR4; the disease is neuroblastoma.